“…Interesting approaches were to compare the transcriptome of self-limiting versus progressive lung sarcoidosis with fibrotic evolution, to search for sarcoidosis-specific gene signatures compared with tuberculosis, an infectious disease also characterized by granuloma, and/or to identify transcriptome signatures related to disease outcome [129]. A recent study focused on the transcriptional signature in monocytes from sarcoidosis patients and healthy controls by an RNA-sequencing screening of the poly-adenylated (or purified mRNA) fraction of RNA [130]. Among 2446 genes significantly differentially expressed in monocytes between sarcoidosis and controls, the authors identified a downregulation of genes involved in proteasome degradation and ribosomal pathways, and conversely, an upregulation of genes, such as, for example, ATP6AP1 (ATPase H + transporting accessory protein 1), CYBB (cytochrome b-245 beta chain), LAMP2 (lysosomal-associated membrane protein), PLK1 (serine/threonine-protein kinase or polo-kinase 1), and SERPINA1 (serpin family A member 1, encoding alpha-1 antitrypsin), implicated in phagocytosis and lysosomal pathways.…”